This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
BB&T Corporation (BBT - Free Report) is slated to announce second-quarter 2018 results on Jul 19, before the market opens. Per the Fed’s latest data, commercial and industrial loans recorded solid growth, with the quarter witnessing an overall modest improvement in lending activities. Notably, BB&T anticipates total loans, on an annualized basis, to grow 1-3% sequentially in the to-be-reported quarter.
BBT STT STI.WS.B STI.WS.A STT.PRC STT.PRE STT.PRD STT.PRG SGH USB STI STI-A VEEV STI.PRE
This is the third month I have officially tracked dividend income (in an article) for John's Traditional and Roth IRA Accounts. His combined dividend income totaled $908.43.
LMT POR RF.PRB RF.PRA SCG KMI.WS HTA O.PRF EPR.PRG LTC RF OPRF TD KMI.PRA KMI MSCA AAPL SCU KMR TD CVB BBT SHBI DUKH GD NYSE TNTTF MAIN O PACW DUK MSCA.CL CLDT OXY KMRFZ
June marks the eighth month I have officially tracked the taxable account's dividend income. The total amount of dividend income received was $676.96.
SOJA ETP.PRC GIS XOM IDCC EPR.PRG O.PRF SKT LTC OPRF BPL SEP COP MIC CINF AAPL CAH EMR BBT SO TLP WLK O MSB OZRK CMI ETP SPG.PRJ HP ORI SPG WPC ADM
Muted trading business is unlikely to support Goldman Sachs’ (GS - Free Report) second-quarter 2018 earnings, to be reported on Jul 17. However, benefits of higher rates and relatively better performance of other segments — mainly investing and lending — are anticipated to aid earnings. Being an investment bank, Goldman is exposed to extreme market volatility. Volatility-driven growth in trading revenues, which supported the top line during the January-March quarter, is likely to have remained muted in the second quarter.
BBT JBK CMA GS.PRICL GSC TFG GS.PRB GS.PRA SAM GSJ GS.PRJ GS.PRI GS GLSSP GS.PRD GS.PRC GJS GS.PRN CFR GS.PRK
In the last five trading days, bank stocks delivered a bullish performance. While escalating trade war between the United States, China and the European Union continued to weigh on investor sentiments, strong economic data on the domestic front largely mitigated this. The latest job market data lessened the concern that the economy is in the late stage of expansion. This news resulted in rising yield on benchmark 10-year Treasury Notes.
WFCNP COF.PRG COF.PRH CMA.WS COF.WS WFC.PRL COF.PRP WFC.PRJ KEY FITBI SAM CMPWW BAC USB COF-D WFC.PRT COF-C COF-F WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN WFC.PRY COF.PRC WFC.PRX COF.PRD WFC.PRW WFC.PRV COF.PRF BBT WFC WFC.WS BAC C COF-P CMA COF OZRK BLK FITB
In the last four trading days, bank stocks put up a lackluster show. Mortgage rates declined in the week, hitting 4.52%, along with bond yields, on escalating trade issues between United States and its major trade allies. This weighed on investor sentiments. However, homeowners seeking lower rates for refinancing are turning out to be big-time gainers. Further, the benchmark 10-year Treasury yield shrunk this week as demand for safe-haven assets increased.
WFCNP COF.PRG COF.PRH RF.PRB RF.PRA FRC COF.WS WFC.PRL RF COF.PRP WFC.PRJ BAC USB COF-D FRC.PRA WFC.PRT COF-C COF-F WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN FRC.PRI FRC.PRH FRC.PRG FRC.PRF WFC.PRY 3772 WFC.PRX COF.PRC FRC.PRE COF.PRD FRC.PRD WFC.PRW FRC.PRC WFC.PRV COF.PRF FRC.PRB BBT WFC WFC.WS BAC C COF-P COF OZRK
With an aim to further expand its insurance business, BB&T Corporation (BBT - Free Report) through its wholly owned subsidiary, BB&T Insurance Holdings, Inc. has acquired Regions Insurance Group. The financial terms of the transaction, announced in April, were not disclosed. Regions Insurance is a subsidiary of Regions Financial Corporation (RF - Free Report) . Regions Insurance, providing property and casualty insurance and employee benefits products, serves more than 60,000 clients across the Southeast, Texas and Indiana through 30 offices.
BBT RF.PRB RF.PRA RF EWBC
The Fed will be announcing the results of bank stress tests on Jun 21 and results of its Comprehensive Capital Analysis Review ("CCAR") on Jun 28. The tests, which are an annual affair and a must for banks since the 2008 financial meltdown, are designed to ensure that they are in a healthy position to handle crisis during an economic downturn. Looking back, President Donald Trump in May signed the biggest rollback of bank regulations since the global economic downturn into law.
C.WSA BNPQY GS.PRB GS.PRA 83SF GLSSP DBXFF 83SK STI-A UBS.PRDCL MS DBFBF STI.WS.B STI.WS.A CSSLF DBAGF GS.PRJ GS.PRI BNPZY GS.PRD GS.PRC DBZQF GS.PRN DBTMF GS.PRK BCS.PRD DB BCS.PRC DGLD BCS.PRA WFC.PRL WFC.PRJ CS BAC WFC.PRT C.WS.B WFC.PRR DBCBW WFC.PRQ WFC.PRP WFC.PRO C.WS.A WFC.PRN C.PRP DBQFF C.PRU WFC.PRY WFC.PRX WFC.PRW WFC.PRV 47MC C.PRS RY C.PRL VIIX GSC GS.PRICL C.PRJ VIIZ C.PRK BNPQF C.PRG DBZFF GSJ C.PRC CSGKF C.PRPCL TVIX GJS ULSGF DBWQF XIV DBFFF BCS MS.PRE MS.PRF MS.PRG MS.PRA UGLD DBCQF BBT JBK BAC DSLV TFG DBFMF DBWGF RY STI MS.PRI MS.PRK CGBBW WFCNP DBQZF DBWFF GS UBS STI.PRE WFC WFC.WS C BCS.PR DBYQF ZIV USLV
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to BBT / BB&T Corp. on message board site Silicon Investor.
as of ET